Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Sundahl, N. Tree, A. Parker, C. (2020). The Emerging Role of Local Therapy in Metastatic Prostate Cancer. Current oncology reports, Vol.22 (1).

Tree, A.C. Dearnaley, D.P. (2020). Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer. Clinical oncology, Vol.32 (3), pp. 175-180.

Murray, J.R. Tree, A.C. Alexander, E.J. Sohaib, A. Hazell, S. Thomas, K. Gunapala, R. Parker, C.C. Huddart, R.A. Gao, A. Truelove, L. McNair, H.A. Blasiak-Wal, I. deSouza, N.M. Dearnaley, D. (2020). Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial. International journal of radiation oncology*biology*physics, Vol.106 (4), pp. 715-724.

Barnes, H. Mohajer, J. Dunlop, A. Adair Smith, G. Herbert, T. Lawes, R. Tree, A. McNair, H. (2020). Laser-free pelvic alignment in an online adaptive radiotherapy environment. Technical innovations & patient support in radiation oncology, Vol.13, pp. 21-23.

Tree, A.C. (2020). Yesterday's News is Today's Fish and Chip Paper. Clinical oncology, Vol.32 (3), pp. 133-135.

Menten, M.J. Mohajer, J.K. Nilawar, R. Bertholet, J. Dunlop, A. Pathmanathan, A.U. Moreau, M. Marshall, S. Wetscherek, A. Nill, S. Tree, A.C. Oelfke, U. (2020). Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging. Radiotherapy and oncology, Vol.145, pp. 88-94.

Patel, P.H. Shiarli, A.-. Tree, A.C. McDonald, F. Palma, D. Gomez, D.R. (2020). Local Treatment of ‘Oligometastases’: Wishful Thinking is Not Supported by Available Evidence – Authors' Reply. Clinical oncology, Vol.32 (6), pp. 409-410.

Dunlop, A. Mitchell, A. Tree, A. Barnes, H. Bower, L. Chick, J. Goodwin, E. Herbert, T. Lawes, R. McNair, H. McQuaid, D. Mohajer, J. Nilawar, R. Pathmanathan, A. Smith, G. Hanson, I. Nill, S. Oelfke, U. (2020). Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac. Clinical and translational radiation oncology, Vol.23, pp. 35-42.

Zaorsky, N.G. Yu, J.B. McBride, S.M. Dess, R.T. Jackson, W.C. Mahal, B.A. Chen, R. Choudhury, A. Henry, A. Syndikus, I. Mitin, T. Tree, A. Kishan, A.U. Spratt, D.E. (2020). Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Advances in radiation oncology, Vol.5 (4), pp. 659-665.

Hall, W.A. Paulson, E. Davis, B.J. Spratt, D.E. Morgan, T.M. Dearnaley, D. Tree, A.C. Efstathiou, J.A. Harisinghani, M. Jani, A.B. Buyyounouski, M.K. Pisansky, T.M. Tran, P.T. Karnes, R.J. Chen, R.C. Cury, F.L. Michalski, J.M. Rosenthal, S.A. Koontz, B.F. Wong, A.C. Nguyen, P. Hope, T.A. Feng, F. Sandler, H.M. Lawton, C.A. (2020). NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Post-Operative Prostate Cancer. International journal of radiation oncology*biology*physics, .

Pathmanathan, A.U. McNair, H.A. Schmidt, M.A. Brand, D.H. Delacroix, L. Eccles, C.L. Gordon, A. Herbert, T. van As, N.J. Huddart, R.A. Tree, A.C. (2019). Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy. Br j radiol, Vol.92 (1095), pp. 20180948-20180948.  show abstract

Pathmanathan, A.U. Schmidt, M.A. Brand, D.H. Kousi, E. As, N.J. Tree, A.C. (2019). Improving fiducial and prostate capsule visualization for radiotherapy planning usingMRI. Journal of applied clinical medical physics, Vol.20 (3), pp. 27-36.

Bashir, U. Tree, A. Mayer, E. Levine, D. Parker, C. Dearnaley, D. Oyen, W.J. (2019). Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy. European journal of nuclear medicine and molecular imaging, Vol.46 (4), pp. 901-907.

Murray, J. Tree, A.C. (2019). Prostate cancer – Advantages and disadvantages of MR-guided RT. Clinical and translational radiation oncology, Vol.18, pp. 68-73.

Patel, P.H. Palma, D. McDonald, F. Tree, A.C. (2019). The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?. Clinical oncology, Vol.31 (12), pp. 824-833.

De Bleser, E. Jereczek-Fossa, B.A. Pasquier, D. Zilli, T. Van As, N. Siva, S. Fodor, A. Dirix, P. Gomez-Iturriaga, A. Trippa, F. Detti, B. Ingrosso, G. Triggiani, L. Bruni, A. Alongi, F. Reynders, D. De Meerleer, G. Surgo, A. Loukili, K. Miralbell, R. Silva, P. Chander, S. Di Muzio, N.G. Maranzano, E. Francolini, G. Lancia, A. Tree, A. Deantoni, C.L. Ponti, E. Marvaso, G. Goetghebeur, E. Ost, P. (2019). Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy. European urology, Vol.76 (6), pp. 732-739.

Brand, D.H. Parker, J.I. Dearnaley, D.P. Eeles, R. Huddart, R. Khoo, V. Murray, J. Suh, Y.-. Tree, A.C. van As, N. Parker, C. (2019). Patterns of recurrence after prostate bed radiotherapy. Radiotherapy and oncology, Vol.141, pp. 174-180.

Tree, A.C. (2019). Stereotactic Body Radiotherapy in Metastatic Disease: The Known Unknowns and the Unknown Unknowns. Clinical oncology, Vol.31 (12), pp. 813-814.

Tree, A. Dearnaley, D. (2018). Randomised Controlled Trials Remain the Key to Progress in Localised Prostate Cancer. European urology, Vol.73 (1), pp. 21-22.

Hanna, G.G. Murray, L. Patel, R. Jain, S. Aitken, K.L. Franks, K.N. van As, N. Tree, A. Hatfield, P. Harrow, S. McDonald, F. Ahmed, M. Saran, F.H. Webster, G.J. Khoo, V. Landau, D. Eaton, D.J. Hawkins, M.A. (2018). UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy. Clinical oncology, Vol.30 (1), pp. 5-14.

Pathmanathan, A.U. van As, N.J. Kerkmeijer, L.G. Christodouleas, J. Lawton, C.A. Vesprini, D. van der Heide, U.A. Frank, S.J. Nill, S. Oelfke, U. van Herk, M. Li, X.A. Mittauer, K. Ritter, M. Choudhury, A. Tree, A.C. (2018). Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A “Game Changer” for Prostate Treatment?. International journal of radiation oncology*biology*physics, Vol.100 (2), pp. 361-373.

Tree, A.C. Jones, K. Hafeez, S. Sharabiani, M.T. Harrington, K.J. Lalondrelle, S. Ahmed, M. Huddart, R.A. (2018). Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer. International journal of radiation oncology*biology*physics, Vol.101 (5), pp. 1168-1171.

Henderson, D.R. Murray, J.R. Gulliford, S.L. Tree, A.C. Harrington, K.J. Van As, N.J. (2018). An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity. Clinical oncology, Vol.30 (9), pp. 539-547.

Grimwood, A. McNair, H.A. O'Shea, T.P. Gilroy, S. Thomas, K. Bamber, J.C. Tree, A.C. Harris, E.J. (2018). In Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy. International journal of radiation oncology*biology*physics, Vol.102 (4), pp. 912-921.

Tree, A.C. Huddart, R. Choudhury, A. (2018). Magnetic Resonance-guided Radiotherapy — Can We Justify More Expensive Technology?. Clinical oncology, Vol.30 (11), pp. 677-679.

Alexander, S.E. Kinsella, J. McNair, H.A. Tree, A.C. (2018). National survey of fiducial marker insertion for prostate image guided radiotherapy. Radiography, Vol.24 (4), pp. 275-282.

Benjamin, L.C. Tree, A.C. Dearnaley, D.P. (2017). The Role of Hypofractionated Radiotherapy in Prostate Cancer. Curr oncol rep, Vol.19 (4), pp. 30-30.  show abstract

Bianchini, D. Lorente, D. Rescigno, P. Zafeiriou, Z. Psychopaida, E. O'Sullivan, H. Alaras, M. Kolinsky, M. Sumanasuriya, S. Sousa Fontes, M. Mateo, J. Perez Lopez, R. Tunariu, N. Fotiadis, N. Kumar, P. Tree, A. Van As, N. Khoo, V. Parker, C. Eeles, R. Thompson, A. Dearnaley, D. de Bono, J.S. (2017). Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital. Clinical genitourinary cancer, Vol.15 (5), pp. e801-e807.

Patrikidou, A. Uccello, M. Tree, A. Parker, C. Attard, G. Eeles, R. Khoo, V. van As, N. Huddart, R. Dearnaley, D. Reid, A. (2017). Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate Cancer. Clinical oncology, Vol.29 (10), pp. e174-e175.

Ost, P. Jereczek-Fossa, B.A. As, N.V. Zilli, T. Muacevic, A. Olivier, K. Henderson, D. Casamassima, F. Orecchia, R. Surgo, A. Brown, L. Tree, A. Miralbell, R. De Meerleer, G. (2016). Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis. European urology, Vol.69 (1), pp. 9-12.

Henderson, D.R. Murray, J.R. Tree, A.C. Riley, U. Rosenfelder, N.A. Murray, D. Khoo, V.S. van As, N.J. (2016). Targeted Antibiotic Prophylaxis for Transrectal Fiducial Marker Insertion for Prostate Radiotherapy. Clinical oncology, Vol.28 (3), pp. 226-227.

McPartlin, A.J. Li, X.A. Kershaw, L.E. Heide, U. Kerkmeijer, L. Lawton, C. Mahmood, U. Pos, F. van As, N. van Herk, M. Vesprini, D. van der Voort van Zyp, J. Tree, A. Choudhury, A. (2016). MRI-guided prostate adaptive radiotherapy – A systematic review. Radiotherapy and oncology, Vol.119 (3), pp. 371-380.

Bedford, J.L. Smyth, G. Hanson, I.M. Tree, A.C. Dearnaley, D.P. Hansen, V.N. (2016). Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity-modulated radiation therapy and volumetric modulated arc therapy for prostate cancer. Radiotherapy and oncology, Vol.120 (2), pp. 320-326.

Ost, P. Jereczek-Fossa, B.A. Van As, N. Zilli, T. Tree, A. Henderson, D. Orecchia, R. Casamassima, F. Surgo, A. Miralbell, R. De Meerleer, G. (2016). Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences. Clinical oncology, Vol.28 (9), pp. e115-e120.

Pathmanathan, A.U. Alexander, E.J. Huddart, R.A. Tree, A.C. (2016). The delineation of intraprostatic boost regions for radiotherapy using multimodality imaging. Future oncol, Vol.12 (21), pp. 2495-2511.  show abstract

Henderson, D. Murray, J. Tree, A. Riley, U. Murray, D. van As, N. (2015). Fiducial Marker Insertion for Image-guided Radiotherapy for Prostate Cancer: What is the Infection Rate and can Targeted Antibiotic Prophylaxis Reduce this?. Clinical oncology, Vol.27 (3), pp. e5-e5.

Henderson, D.R. Tree, A.C. van As, N.J. (2015). Stereotactic Body Radiotherapy for Prostate Cancer. Clinical oncology, Vol.27 (5), pp. 270-279.

Aitken, K. Tree, A. Thomas, K. Nutting, C. Hawkins, M. Tait, D. Mandeville, H. Ahmed, M. Lalondrelle, S. Miah, A. Taylor, A. Ross, G. Khoo, V. van As, N. (2015). Initial UK Experience of Stereotactic Body Radiotherapy for Extracranial Oligometastases: Can We Change the Therapeutic Paradigm?. Clinical oncology, Vol.27 (7), pp. 411-419.

Tree, A. Ostler, P. van As, N. (2014). New Horizons and Hurdles for UK Radiotherapy: Can Prostate Stereotactic Body Radiotherapy Show the Way?. Clinical oncology, Vol.26 (1), pp. 1-3.

Tree, A. Ostler, P. Hoskin, P. Dankulchai, P. Khoo, V. van As, N. (2014). First UK Cohort of Prostate Stereotactic Body Radiotherapy (SBRT): Acute Toxicity and Early Prostate-specific Antigen (PSA) Outcomes. Clinical oncology, Vol.26 (2), pp. e7-e7.

Tree, A.C. Khoo, V.S. van As, N.J. Partridge, M. (2014). Is Biochemical Relapse-free Survival After Profoundly Hypofractionated Radiotherapy Consistent with Current Radiobiological Models?. Clinical oncology, Vol.26 (4), pp. 216-229.

Tree, A. Siu, B. Townsend-Thorn, D. Murray, D. Riley, U. Khoo, V. van As, N. (2014). The Incidence of Ciprofloxacin Resistance in Patients Undergoing Gold Seed Insertion for Image-guided Prostate Radiotherapy. Clinical oncology, Vol.26, pp. S8-S8.

Tree, A.C. Ostler, P. Hoskin, P. Dankulchai, P. Nariyangadu, P. Hughes, R.J. Wells, E. Taylor, H. Khoo, V.S. van As, N.J. (2014). Prostate Stereotactic Body Radiotherapy — First UK Experience. Clinical oncology, Vol.26 (12), pp. 757-761.

Tree, A.C. Khoo, V.S. Eeles, R.A. Ahmed, M. Dearnaley, D.P. Hawkins, M.A. Huddart, R.A. Nutting, C.M. Ostler, P.J. van As, N.J. (2013). Stereotactic body radiotherapy for oligometastases. Lancet oncol, Vol.14 (1), pp. e28-e37.  show abstract

Tree, A. Wells, E. Khoo, V. van As, N. (2013). Hypofractionated Radiotherapy with Cyberknife for Localised Prostate Cancer: Early Experience. Clinical oncology, Vol.25 (4), pp. e72-e73.

Tree, A.C. Alexander, E.J. Van As, N.J. Dearnaley, D.P. Khoo, V. (2013). Biological Dose Escalation and Hypofractionation: What is There to be Gained and How Will it Best be Done?. Clinical oncology, Vol.25 (8), pp. 483-498.

Tree, A. Jones, C. Sohaib, A. Khoo, V. van As, N. (2013). Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?. Radiation oncology, Vol.8 (1).

Creak, A.L. Tree, A. Saran, F. (2011). Radiotherapy Planning in High-grade Gliomas: a Survey of Current UK Practice. Clinical oncology, Vol.23 (3), pp. 189-198.

Partridge, M. Tree, A. Brock, J. McNair, H. Fernandez, E. Panakis, N. Brada, M. (2009). Improvement in tumour control probability with active breathing control and dose escalation: A modelling study. Radiotherapy and oncology, Vol.91 (3), pp. 325-329.

Henderson, D. Tree, A. Harrington, K. van As, N. Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer. Medicines, Vol.5 (2), pp. 32-32.

de Muinck Keizer, D.M. Pathmanathan, A.U. Andreychenko, A. Kerkmeijer, L.G. van der Voort van Zyp, J.R. Tree, A.C. van den Berg, C.A. de Boer, J.C. Fiducial marker based intra-fraction motion assessment on cine-MR for MR-linac treatment of prostate cancer. Physics in medicine & biology, Vol.64 (7), pp. 07NT02-07NT02.

Hall, E. Brand, D. Tree, A. Ostler, P. van der Voet, H. Loblaw, A. Chu, W. Ford, D. Tolan, S. Jain, S. Martin, A. Staffurth, J. Camilleri, P. Kancherla, K. Frew, J. Chan, A. Dayes, I. Henderson, D. Brown, S. Cruickshank, C. Burnett, S. Duffton, A. Griffin, C. Hinder, V. Morrison, K. Naismith, O. van As, N. Intensity Modulated Fractionated Radiotherapy Versus Stereotactic Body Radiotherapy for Prostate Cancer (PACE-B): Acute Toxicity Results From a Randomised Open-label Phase III Non-inferiority Trial. The lancet oncology, .

Harris, E. Tree, A. McNair, H. Grimwood, A. Bamber, J. hassan, R. Hang, Z. Improving 3D ultrasound prostate localisation in radiotherapy through increased automation of interfraction matching. Radiotherapy and oncology, .


Conferences

Kumar, R.Walder, D.P.Pejanaute, A.Gunapala, R.Bhosle, J.Yousef, N.Popat, S.McDonald, F.Locke, I.Harrington, K.Tree, A.Lalondrelle, S.Huddart, R.O’Brien, M.E.Ahmed, M. (2018). Phase I dose escalation of pembrolizumab given concurrently with palliative thoracic radiotherapy (RT) for NSCLC, Annals of Oncology, Vol.29, p.viii530.

Henderson, D.R.Tree, A.Taylor, H.Khoo, V.Van As, N.J. (2015). Oligometastatic prostate cancer: An evaluation of stereotactic body radiotherapy (SBRT) as an alternative to palliative androgen deprivation therapy., Journal of Clinical Oncology, Vol.33 (7_suppl), p.229.

Henderson, D.R.Tree, A.van As, N. (2015). Stereotactic Body Radiation Therapy Planning for Localized Prostate Cancer in the PACE Phase 3 Trial: Can This Be Done Without Fused Planning MRI?, International Journal of Radiation Oncology*Biology*Physics, Vol.93 (3), p.E202.

Tree, A.C.Khoo, V.S.Van As, N.J. (2013). Salvage stereotactic body radiotherapy in radio-recurrent prostate cancer - what dose is feasible?, EUROPEAN JOURNAL OF CANCER, Vol.49, p.S690.

Tree, A.Aluwini, S.Bryant, H.Hall, E.Incrocci, L.Kaplan, I.Ostler, P.Sanda, M.Thompson, A.van As, N. (2013). Successful Patient Acceptance of Randomization Within the Pace Study (Prostate Advances in Comparative Evidence), International Journal of Radiation Oncology*Biology*Physics, Vol.87 (2), p.S365.

Partridge, M.Tree, A.Brock, J.McNair, H.Fernandez, L.Panakis, N.Brada, M. (2009). Improving Tumour Control Probability with Active Breathing Control and Dose Escalation, CLINICAL ONCOLOGY, Vol.21 (3), p.250.


Reports

Gnanapragasam, V.J.Hori, S.Johnston, T.Smith, D.Muir, K.Alonzi, R.Winkler, M.Warren, A.Staffurth, J.Khoo, V.Tree, A.Macneill, A.McMenemin, R.Mason, M.Cathcart, P.de Souza, N.Sooriakumaran, P.Weston, R.Wylie, J.Hall, E.Lane, A.Cross, W.Syndikus, I.Koupparis, A. (2016). Clinical management and research priorities for high-risk prostate cancer in the UK: Meeting report of a multidisciplinary panel in conjunction with the NCRI Prostate Cancer Clinical Studies Localised Subgroup.

In this section

Research overview Research projects Publications